Silence Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Silence Therapeutics Stock Summary

Silence Therapeutics competes with Cue Biopharma, Eliem Therapeutics, Inhibrx, and Molecular Partners. Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid therapeutics in hematology, cardiovascular, and other rare and metabolic indications. Silence Therapeutics plc is headquartered in London, the United Kingdom. Silence Therapeutics is traded on NASDAQ Exchange in the United States.

Silence Therapeutics Key Financial Ratios

Silence Therapeutics Key Balance Sheet Accounts

Silence Therapeutics Key Income Statement Accounts

Silence Therapeutics Key Cash Accounts

Silence Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Silence Therapeutics's current stock value. Our valuation model uses many indicators to compare Silence Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Silence Therapeutics competition to find correlations between indicators driving Silence Therapeutics's intrinsic value. More Info.Silence Therapeutics PLC is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, Silence Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Silence Therapeutics' earnings, one of the primary drivers of an investment's value.

Silence Therapeutics PLC Systematic Risk

Today, most investors in Silence Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Silence Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Silence Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Silence Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Silence Therapeutics PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Silence Therapeutics PLC based on widely used predictive technical indicators. In general, we focus on analyzing Silence Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Silence Therapeutics's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.